Back to news
other·

The mRNA Gold Rush: Why Moderna’s “Cancer Vaccine” Hype Will Get Challenged

The mRNA Gold Rush: Why Moderna’s “Cancer Vaccine” Hype Will Get Challenged

Mega-dose weekly mRNA part of toxic chemotherapy, however with rapid FDA approval, Intismeran poised to saddle patients with massive costs, tumor resistance, and accumulating long term safety concerns * After five years of being bashed on unsafe, ineffective,…

Mega-dose weekly mRNA part of toxic chemotherapy, however with rapid FDA approval, Intismeran poised to saddle patients with massive costs, tumor resistance, and accumulating long term safety concerns * After five years of being bashed on unsafe, ineffective,…
Read original at Globalresearch.ca